THERALINK TECHNOLOGIES, INC. (THER) Financial Statements (2024 and earlier)

Company Profile

Business Address 8000 INNOVATION PARK
BATON ROUGE, LA 70820
State of Incorp. NV
Fiscal Year End September 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
MRQ
9/30/2023
9/30/2022
9/30/2021
9/30/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9983973251,790210
Cash and cash equivalents9973933141,779210
Short-term investments141111  
Receivables2432    
Deferred costs  27    
Other undisclosed current assets24019031427841216
Total current assets:1,2636476392,06862216
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization1965111158 
Operating lease, right-of-use asset1,1041,15516920624
Property, plant and equipment44968669974524
Deferred costs  27    
Other undisclosed noncurrent assets1519211966
Total noncurrent assets:1,5871,9521,0001,1283211
TOTAL ASSETS:2,8502,5991,6393,19694227
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3741,2321,2367462,1751,434
Interest and dividends payable4013   
Employee-related liabilities19313373  
Accounts payable  7311,019617620550
Accrued liabilities37426871571,554884
Deferred revenue145157135  
Debt305549433,4781,973
Deferred compensation liability9438318633  
Derivative instruments and hedges, liabilities16,426   9,3203,364
Disposal group, including discontinued operation    205687687
Business combination, contingent consideration, liability8678    
Other liabilities 12,976 71   
Due to related parties 1,122 373315
Other undisclosed current liabilities9,7041,551498164  
Total current liabilities:39,8353,4563,2961,19116,0327,774
Noncurrent Liabilities
Long-term debt and lease obligation 41,638288313  
Long-term debt, excluding current maturities  44665   
Finance lease, liability 43488136 
Liabilities, other than long-term debt1,126     
Operating lease, liability1,1261,158134177 
Other undisclosed noncurrent liabilities  148(134)(177)  
Total noncurrent liabilities:1,1312,944288313  
Total liabilities:40,9656,4003,5841,50416,0327,774
Temporary equity, carrying amount    2,000  
Equity
Equity, attributable to parent, including:(38,116)(6,801)(4,945)(308)(15,937)(7,547)
Common stock615615512512025
Additional paid in capital55,02455,39244,36842,36810,6529,613
Accumulated deficit(93,755)(62,808)(49,826)(43,188)(26,590)(17,188)
Other undisclosed equity, attributable to parent     03
Other undisclosed equity  3,0003,000   
Total equity:(38,116)(3,801)(1,945)(308)(15,937)(7,547)
TOTAL LIABILITIES AND EQUITY:2,8502,5991,6393,19694227

Income Statement (P&L) ($ in thousands)

12/31/2023
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
12/31/2019
12/31/2018
Revenues125568506181  
Cost of revenue(126)(225)(117)(53)  
Other undisclosed gross profit482     
Gross profit:481343388129  
Operating expenses(9,460)(11,983)(5,954)(3,485)(1,769)(1,778)
Operating loss:(8,979)(11,640)(5,566)(3,357)(1,769)(1,778)
Nonoperating income (expense)(21,928)(1,102)94187(7,634)8,246
Gain (loss), foreign currency transaction, before tax   (23)49 34
Interest and debt expense(5,434)(1,095)227165(77)2,114
Income (loss) from continuing operations before income taxes:(36,342)(13,837)(5,244)(3,005)(9,480)8,583
Other undisclosed income (loss) from continuing operations     77(2,114)
Income (loss) from continuing operations:(36,342)(13,837)(5,244)(3,005)(9,402)6,468
Income (loss) before gain (loss) on sale of properties:(13,837)(5,244)(3,005)(9,402)6,468
Net income (loss):(36,342)(13,837)(5,244)(3,005)(9,402)6,468
Other undisclosed net income (loss) attributable to parent5,4341,095(227)(165)  
Net income (loss) attributable to parent:(30,908)(12,742)(5,472)(3,170)(9,402)6,468
Preferred stock dividends and other adjustments    (2,006)  
Other undisclosed net loss available to common stockholders, basic (39)(240)(1,167)   
Net income (loss) available to common stockholders, basic:(30,947)(12,982)(6,638)(5,176)(9,402)6,468
Interest on convertible debt      
Dilutive securities, effect on basic earnings per share      
Net income (loss) available to common stockholders, diluted:(30,947)(12,982)(6,638)(5,176)(9,402)6,468

Comprehensive Income ($ in thousands)

12/31/2023
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
12/31/2019
12/31/2018
Net income (loss):(36,342)(13,837)(5,244)(3,005)(9,402)6,468
Other comprehensive income      6,443
Comprehensive income (loss), net of tax, attributable to parent:(36,342)(13,837)(5,244)(3,005)(9,402)12,911

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: